{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:03:29Z","timestamp":1794636209566,"version":"4.9.1"},"reference-count":219,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41585-025-01065-z","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:02:10Z","timestamp":1754035330000},"page":"799-814","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["CAUTIon \u2014 not all UTIs are the same"],"prefix":"10.1038","volume":"22","author":[{"given":"Jonathan J.","family":"Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4610-4246","authenticated-orcid":false,"given":"Ana L.","family":"Flores-Mireles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"1065_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00345-024-04979-2","volume":"42","author":"Z Tandogdu","year":"2024","unstructured":"Tandogdu, Z. et al. Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study. World J. Urol. 42, 314 (2024).","journal-title":"World J. Urol."},{"key":"1065_CR2","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1001\/jama.2014.4107","volume":"311","author":"BM Kuehn","year":"2014","unstructured":"Kuehn, B. M. Some progress in effort to reduce hospital-acquired infections. JAMA 311, 1488 (2014).","journal-title":"JAMA"},{"key":"1065_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/003335490712200205","volume":"122","author":"RM Klevens","year":"2007","unstructured":"Klevens, R. M. et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public. Health Rep. 122, 160\u2013166 (2007).","journal-title":"Public. Health Rep."},{"key":"1065_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman, B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North. Am. 28, 1\u201313 (2014).","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"1065_CR5","first-page":"109","volume":"14","author":"GT Werneburg","year":"2022","unstructured":"Werneburg, G. T. Catheter-associated urinary tract infections: current challenges and future prospects. Res. Rep. Urol. 14, 109\u2013133 (2022).","journal-title":"Res. Rep. Urol."},{"key":"1065_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.888205","volume":"10","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Disease burden and long-term trends of urinary tract infections: a worldwide report. Front. Public. Health 10, 888205 (2022).","journal-title":"Front. Public. Health"},{"key":"1065_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles, A. L., Walker, J. N., Caparon, M. & Hultgren, S. J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13, 269\u2013284 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"1065_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/1756287219832172","volume":"11","author":"M Medina","year":"2019","unstructured":"Medina, M. & Castillo-Pino, E. An introduction to the epidemiology and burden of urinary tract infections. Ther. Adv. Urol. 11, 1756287219832172 (2019).","journal-title":"Ther. Adv. Urol."},{"key":"1065_CR9","unstructured":"United States Center for Disease Control and Prevention. Urinary Tract Infections Basics. CDC https:\/\/www.cdc.gov\/uti\/about\/index.html (2024)."},{"key":"1065_CR10","first-page":"40","volume":"20","author":"K Czajkowski","year":"2021","unstructured":"Czajkowski, K., Bros-Konopielko, M. & Teliga-Czajkowska, J. Urinary tract infection in women. Prz. Menopauzalny 20, 40\u201347 (2021).","journal-title":"Prz. Menopauzalny"},{"key":"1065_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.eclinm.2019.07.012","volume":"14","author":"M Pujades-Rodriguez","year":"2019","unstructured":"Pujades-Rodriguez, M., West, R. M., Wilcox, M. H. & Sandoe, J. Lower urinary tract infections: management, outcomes and risk factors for antibiotic re-prescription in primary care. EClinicalMedicine 14, 23\u201331 (2019).","journal-title":"EClinicalMedicine"},{"key":"1065_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13756-023-01282-4","volume":"12","author":"SWC Koh","year":"2023","unstructured":"Koh, S. W. C. et al. Antibiotic treatment failure of uncomplicated urinary tract infections in primary care. Antimicrob. Resist. Infect. Control. 12, 73 (2023).","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"1065_CR13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2016.09.003","volume":"22","author":"LK McLellan","year":"2016","unstructured":"McLellan, L. K. & Hunstad, D. A. Urinary tract infection: pathogenesis and outlook. Trends Mol. Med. 22, 946\u2013957 (2016).","journal-title":"Trends Mol. Med."},{"key":"1065_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1310\/sci2503-228","volume":"25","author":"A Flores-Mireles","year":"2019","unstructured":"Flores-Mireles, A., Hreha, T. N. & Hunstad, D. A. Pathophysiology, treatment, and prevention of catheter-associated urinary tract infection. Top. Spinal Cord. Inj. Rehabil. 25, 228\u2013240 (2019).","journal-title":"Top. Spinal Cord. Inj. Rehabil."},{"key":"1065_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","volume":"17","author":"FME Wagenlehner","year":"2020","unstructured":"Wagenlehner, F. M. E. et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat. Rev. Urol. 17, 586\u2013600 (2020).","journal-title":"Nat. Rev. Urol."},{"key":"1065_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1086\/675718","volume":"35","author":"E Lo","year":"2014","unstructured":"Lo, E. et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect. Control. Hosp. Epidemiol. 35, 464\u2013479 (2014).","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"1065_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1128\/CMR.00019-07","volume":"21","author":"SM Jacobsen","year":"2008","unstructured":"Jacobsen, S. M., Stickler, D. J., Mobley, H. L. & Shirtliff, M. E. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21, 26\u201359 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"1065_CR18","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.176","volume":"3","author":"BJ Langford","year":"2023","unstructured":"Langford, B. J. et al. Antibiotic selection and duration for catheter-associated urinary tract infection in non-hospitalized older adults: a population-based cohort study. Antimicrob. Steward. Healthc. Epidemiol. 3, e132 (2023).","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"1065_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/jgid.jgid_104_17","volume":"10","author":"R Paul","year":"2018","unstructured":"Paul, R. State of the globe: rising antimicrobial resistance of pathogens in urinary tract infection. J. Glob. Infect. Dis. 10, 117\u2013118 (2018).","journal-title":"J. Glob. Infect. Dis."},{"key":"1065_CR20","unstructured":"Haider, M.Z. & Annamaraju, P. Bladder Catheterization. StatPearls [Internet] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560748 (updated 9 August 2023)."},{"key":"1065_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.ajic.2023.08.019","volume":"51","author":"R Wilson Dib","year":"2023","unstructured":"Wilson Dib, R. et al. The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center. Am. J. Infect. Control. 51, 1302\u20131308 (2023).","journal-title":"Am. J. Infect. Control."},{"key":"1065_CR22","unstructured":"United States Center for Disease Control and Prevention. COVID-19 Impact on Healthcare-associated Infections. CDC https:\/\/www.cdc.gov\/healthcare-associated-infections\/php\/data\/covid-impact.html (2024)."},{"key":"1065_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.WON.0000345173.05376.3e","volume":"36","author":"D Parker","year":"2009","unstructured":"Parker, D. et al. Nursing interventions to reduce the risk of catheter-associated urinary tract infection. Part 1: catheter selection. J. Wound Ostomy Cont. Nurs. 36, 23\u201334 (2009).","journal-title":"J. Wound Ostomy Cont. Nurs."},{"key":"1065_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/TA.0000000000000822","volume":"79","author":"AS Jarrell","year":"2015","unstructured":"Jarrell, A. S. et al. Short-duration treatment for catheter-associated urinary tract infections in critically ill trauma patients. J. Trauma. Acute Care Surg. 79, 649\u2013653 (2015).","journal-title":"J. Trauma. Acute Care Surg."},{"key":"1065_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/01.WON.0000347655.56851.04","volume":"36","author":"M Willson","year":"2009","unstructured":"Willson, M. et al. Nursing interventions to reduce the risk of catheter-associated urinary tract infection: part 2: staff education, monitoring, and care techniques. J. Wound Ostomy Cont. Nurs. 36, 137\u2013154 (2009).","journal-title":"J. Wound Ostomy Cont. Nurs."},{"key":"1065_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3201\/eid0702.010240","volume":"7","author":"DG Maki","year":"2001","unstructured":"Maki, D. G. & Tambyah, P. A. Engineering out the risk for infection with urinary catheters. Emerg. Infect. Dis. 7, 342\u2013347 (2001).","journal-title":"Emerg. Infect. Dis."},{"key":"1065_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/oxfordjournals.aje.a116283","volume":"135","author":"CM Kunin","year":"1992","unstructured":"Kunin, C. M., Douthitt, S., Dancing, J., Anderson, J. & Moeschberger, M. The association between the use of urinary catheters and morbidity and mortality among elderly patients in nursing homes. Am. J. Epidemiol. 135, 291\u2013301 (1992).","journal-title":"Am. J. Epidemiol."},{"key":"1065_CR28","first-page":"837","volume":"112","author":"NM Dreger","year":"2015","unstructured":"Dreger, N. M., Degener, S., Ahmad-Nejad, P., Wobker, G. & Roth, S. Urosepsis \u2014 etiology, diagnosis, and treatment. Dtsch. Arztebl Int. 112, 837\u2013847 (2015). quiz 848.","journal-title":"Dtsch. Arztebl Int."},{"key":"1065_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jinf.2010.12.004","volume":"62","author":"VD Rosenthal","year":"2011","unstructured":"Rosenthal, V. D. et al. Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings. J. Infect. 62, 136\u2013141 (2011).","journal-title":"J. Infect."},{"key":"1065_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/archinte.164.8.842","volume":"164","author":"BW Trautner","year":"2004","unstructured":"Trautner, B. W. & Darouiche, R. O. Catheter-associated infections: pathogenesis affects prevention. Arch. Intern. Med. 164, 842\u2013850 (2004).","journal-title":"Arch. Intern. Med."},{"key":"1065_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QCO.0b013e32835565cc","volume":"25","author":"PA Tambyah","year":"2012","unstructured":"Tambyah, P. A. & Oon, J. Catheter-associated urinary tract infection. Curr. Opin. Infect. Dis. 25, 365\u2013370 (2012).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"1065_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0891-5520(05)70376-7","volume":"11","author":"JW Warren","year":"1997","unstructured":"Warren, J. W. Catheter-associated urinary tract infections. Infect. Dis. Clin. North. Am. 11, 609\u2013622 (1997).","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"1065_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.7326\/0003-4819-144-2-200601170-00009","volume":"144","author":"JR Johnson","year":"2006","unstructured":"Johnson, J. R., Kuskowski, M. A. & Wilt, T. J. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann. Intern. Med. 144, 116\u2013126 (2006).","journal-title":"Ann. Intern. Med."},{"key":"1065_CR34","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/archinte.160.5.678","volume":"160","author":"PA Tambyah","year":"2000","unstructured":"Tambyah, P. A. & Maki, D. G. Catheter-associated urinary tract infection is rarely symptomatic \u2014 a prospective study of 1497 catheterized patients. Arch. Intern. Med. 160, 678\u2013682 (2000).","journal-title":"Arch. Intern. Med."},{"key":"1065_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1086\/501964","volume":"23","author":"PA Tambyah","year":"2002","unstructured":"Tambyah, P. A., Knasinski, V. & Maki, D. G. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect. Control. Hosp. Epidemiol. 23, 27\u201331 (2002).","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"1065_CR36","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/cid\/cis556","volume":"55","author":"DJ Morgan","year":"2012","unstructured":"Morgan, D. J. et al. Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing? Clin. Infect. Dis. 55, 923\u2013929 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"1065_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1086\/651091","volume":"31","author":"CV Gould","year":"2010","unstructured":"Gould, C. V. et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect. Control. Hosp. Epidemiol. 31, 319\u2013326 (2010).","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"1065_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13756-023-01254-8","volume":"12","author":"ML Ling","year":"2023","unstructured":"Ling, M. L. et al. APSIC guide for prevention of catheter associated urinary tract infections (CAUTIs). Antimicrobial Resistance Infect. Control. 12, 52 (2023).","journal-title":"Antimicrobial Resistance Infect. Control."},{"key":"1065_CR39","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamainternmed.2013.101","volume":"173","author":"S Saint","year":"2013","unstructured":"Saint, S. et al. Preventing catheter-associated urinary tract infection in the United States: a national comparative study. JAMA Intern. Med. 173, 874\u2013879 (2013).","journal-title":"JAMA Intern. Med."},{"key":"1065_CR40","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.ajic.2023.04.105","volume":"51","author":"AE Carter","year":"2023","unstructured":"Carter, A. E. et al. Evaluation of CAUTI-reduction strategies and associated reduction in CAUTI rate and catheter utilization at a large academic medical center. Am. J. Infect. Control. 51, S51 (2023).","journal-title":"Am. J. Infect. Control."},{"key":"1065_CR41","doi-asserted-by":"publisher","unstructured":"Hayes, B. W. & Abraham, S. N. Innate immune responses to bladder infection. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.uti-0024-2016 (2016).","DOI":"10.1128\/microbiolspec.uti-0024-2016"},{"key":"1065_CR42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2147\/IDR.S295870","volume":"14","author":"Y Ding","year":"2021","unstructured":"Ding, Y., Wang, H., Pu, S., Huang, S. & Niu, S. Resistance trends of Klebsiella pneumoniae causing urinary tract infections in Chongqing, 2011\u20132019. Infect. Drug. Resist. 14, 475\u2013481 (2021).","journal-title":"Infect. Drug. Resist."},{"key":"1065_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1067\/mda.2003.8","volume":"49","author":"A Ronald","year":"2003","unstructured":"Ronald, A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis. Mon. 49, 71\u201382 (2003).","journal-title":"Dis. Mon."},{"key":"1065_CR44","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajic.2020.10.007","volume":"49","author":"A DeRosa","year":"2021","unstructured":"DeRosa, A. et al. Antimicrobial susceptibility trends for urinary isolates in the veteran population. Am. J. Infect. Control. 49, 576\u2013581 (2021).","journal-title":"Am. J. Infect. Control."},{"key":"1065_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41564-022-01113-z","volume":"7","author":"MA Schembri","year":"2022","unstructured":"Schembri, M. A., Nhu, N. T. K. & Phan, M.-D. Gut\u2013bladder axis in recurrent UTI. Nat. Microbiol. 7, 601\u2013602 (2022).","journal-title":"Nat. Microbiol."},{"key":"1065_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41579-020-0324-0","volume":"18","author":"RD Klein","year":"2020","unstructured":"Klein, R. D. & Hultgren, S. J. Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies. Nat. Rev. Microbiol. 18, 211\u2013226 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"1065_CR47","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1128\/AAC.00447-12","volume":"56","author":"PS Guiton","year":"2012","unstructured":"Guiton, P. S. et al. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice. Antimicrob. Agents Chemother. 56, 4738\u20134745 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1065_CR48","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nri3887","volume":"15","author":"SN Abraham","year":"2015","unstructured":"Abraham, S. N. & Miao, Y. The nature of immune responses to urinary tract infections. Nat. Rev. Immunol. 15, 655\u2013663 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1065_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030060","volume":"3","author":"J Song","year":"2007","unstructured":"Song, J. et al. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog. 3, e60 (2007).","journal-title":"PLoS Pathog."},{"key":"1065_CR50","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.kint.2017.12.006","volume":"93","author":"CB Ching","year":"2018","unstructured":"Ching, C. B. et al. Interleukin-6\/Stat3 signaling has an essential role in the host antimicrobial response to urinary tract infection. Kidney Int. 93, 1320\u20131329 (2018).","journal-title":"Kidney Int."},{"key":"1065_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1189\/jlb.3HI0517-198R","volume":"103","author":"A Dixit","year":"2018","unstructured":"Dixit, A. et al. Frontline science: proliferation of Ly6C+ monocytes during urinary tract infections is regulated by IL-6 trans-signaling. J. Leukoc. Biol. 103, 13\u201322 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"1065_CR52","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1128\/IAI.73.7.3999-4006.2005","volume":"73","author":"DA Hunstad","year":"2005","unstructured":"Hunstad, D. A., Justice, S. S., Hung, C. S., Lauer, S. R. & Hultgren, S. J. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect. Immun. 73, 3999\u20134006 (2005).","journal-title":"Infect. Immun."},{"key":"1065_CR53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.micinf.2007.10.012","volume":"10","author":"DW Hilbert","year":"2008","unstructured":"Hilbert, D. W. et al. Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway. Microbes Infect. 10, 114\u2013121 (2008).","journal-title":"Microbes Infect."},{"key":"1065_CR54","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.46677","volume":"8","author":"L Yu","year":"2019","unstructured":"Yu, L. et al. Mucosal infection rewires TNF\u03b1 signaling dynamics to skew susceptibility to recurrence. Elife 8, e46677 (2019).","journal-title":"Elife"},{"key":"1065_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2024.100469","volume":"13","author":"M Al Qahtani","year":"2024","unstructured":"Al Qahtani, M. et al. The incidence, clinical features and outcome of urinary tract infections in geriatric patients: a prospective longitudinal study. IJID Reg. 13, 100469 (2024).","journal-title":"IJID Reg."},{"key":"1065_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007457","volume":"14","author":"VP O\u2019Brien","year":"2018","unstructured":"O\u2019Brien, V. P., Dorsey, D. A., Hannan, T. J. & Hultgren, S. J. Host restriction of Escherichia coli recurrent urinary tract infection occurs in a bacterial strain-specific manner. PLoS Pathog. 14, e1007457 (2018).","journal-title":"PLoS Pathog."},{"key":"1065_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/nmicrobiol.2016.196","volume":"2","author":"VP O\u2019Brien","year":"2016","unstructured":"O\u2019Brien, V. P. et al. A mucosal imprint left by prior Escherichia coli bladder infection sensitizes to recurrent disease. Nat. Microbiol. 2, 16196 (2016).","journal-title":"Nat. Microbiol."},{"key":"1065_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/QCO.0000000000000130","volume":"28","author":"VP O\u2019Brien","year":"2015","unstructured":"O\u2019Brien, V. P., Hannan, T. J., Schaeffer, A. J. & Hultgren, S. J. Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr. Opin. Infect. Dis. 28, 97\u2013105 (2015).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"1065_CR59","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41564-023-01346-6","volume":"8","author":"SK Russell","year":"2023","unstructured":"Russell, S. K. et al. Uropathogenic Escherichia coli infection-induced epithelial trained immunity impacts urinary tract disease outcome. Nat. Microbiol. 8, 875\u2013888 (2023).","journal-title":"Nat. Microbiol."},{"key":"1065_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5409\/wjcp.v2.i4.46","volume":"2","author":"XZ Huang","year":"2013","unstructured":"Huang, X. Z., Zhu, L. B., Li, Z. R. & Lin, J. Bacterial colonization and intestinal mucosal barrier development. World J. Clin. Pediatr. 2, 46\u201353 (2013).","journal-title":"World J. Clin. Pediatr."},{"key":"1065_CR61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ebiom.2014.10.011","volume":"1","author":"TJ Hannan","year":"2014","unstructured":"Hannan, T. J. et al. Inhibition of cyclooxygenase-2 prevents chronic and recurrent cystitis. EBioMedicine 1, 46\u201357 (2014).","journal-title":"EBioMedicine"},{"key":"1065_CR62","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000948","volume":"4","author":"T Ebrahimzadeh","year":"2021","unstructured":"Ebrahimzadeh, T. et al. Urinary prostaglandin E2 as a biomarker for recurrent UTI in postmenopausal women. Life Sci. Alliance 4, e202000948 (2021).","journal-title":"Life Sci. Alliance"},{"key":"1065_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-30","volume":"8","author":"J Bleidorn","year":"2010","unstructured":"Bleidorn, J., Gagyor, I., Kochen, M. M., Wegscheider, K. & Hummers-Pradier, E. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? \u2014 results of a randomized controlled pilot trial. BMC Med. 8, 30 (2010).","journal-title":"BMC Med."},{"key":"1065_CR64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.eursup.2016.10.001","volume":"16","author":"P Tenke","year":"2017","unstructured":"Tenke, P., Mezei, T., B\u0151de, I. & K\u00f6ves, B. Catheter-associated urinary tract infections. Eur. Urol. Suppl. 16, 138\u2013143 (2017).","journal-title":"Eur. Urol. Suppl."},{"key":"1065_CR65","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.juro.2008.06.012","volume":"180","author":"JM Barford","year":"2008","unstructured":"Barford, J. M., Hu, Y., Anson, K. & Coates, A. R. A biphasic response from bladder epithelial cells induced by catheter material and bacteria: an in vitro study of the pathophysiology of catheter related urinary tract infection. J. Urol. 180, 1522\u20131526 (2008).","journal-title":"J. Urol."},{"key":"1065_CR66","first-page":"589","volume":"19","author":"C Agra Leite","year":"2023","unstructured":"Agra Leite, C. & Darbellay Farhoumand, P. [The forgotten urinary catheter]. Rev. Med. Suisse 19, 589\u2013590 (2023).","journal-title":"Rev. Med. Suisse"},{"key":"1065_CR67","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75798","volume":"11","author":"MJ Andersen","year":"2022","unstructured":"Andersen, M. J. et al. Inhibiting host-protein deposition on urinary catheters reduces associated urinary tract infections. Elife 11, e75798 (2022).","journal-title":"Elife"},{"key":"1065_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46974-6","volume":"15","author":"JJ Molina","year":"2024","unstructured":"Molina, J. J. et al. Fibrinolytic-deficiencies predispose hosts to septicemia from a catheter-associated UTI. Nat. Commun. 15, 2704 (2024).","journal-title":"Nat. Commun."},{"key":"1065_CR69","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s44259-024-00046-3","volume":"2","author":"HY Liu","year":"2024","unstructured":"Liu, H. Y., Prentice, E. L. & Webber, M. A. Mechanisms of antimicrobial resistance in biofilms. NPJ Antimicrob. Resist. 2, 27 (2024).","journal-title":"NPJ Antimicrob. Resist."},{"key":"1065_CR70","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajic.2003.08.005","volume":"32","author":"BW Trautner","year":"2004","unstructured":"Trautner, B. W. & Darouiche, R. O. Role of biofilm in catheter-associated urinary tract infection. Am. J. Infect. Control. 32, 177\u2013183 (2004).","journal-title":"Am. J. Infect. Control."},{"key":"1065_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8869275","volume":"2021","author":"WD Gunardi","year":"2021","unstructured":"Gunardi, W. D. et al. Biofilm-producing bacteria and risk factors (gender and duration of catheterization) characterized as catheter-associated biofilm formation. Int. J. Microbiol. 2021, 8869275 (2021).","journal-title":"Int. J. Microbiol."},{"key":"1065_CR72","doi-asserted-by":"publisher","first-page":"e03584","DOI":"10.1128\/mBio.03584-20","volume":"12","author":"SA Wilks","year":"2021","unstructured":"Wilks, S. A., Koerfer, V. V., Prieto, J. A., Fader, M. & Keevil, C. W. Biofilm development on urinary catheters promotes the appearance of viable but nonculturable bacteria. mBio 12, e03584\u201320 (2021).","journal-title":"mBio"},{"key":"1065_CR73","first-page":"64","volume":"8","author":"R Ramadan","year":"2021","unstructured":"Ramadan, R., Omar, N., Dawaba, M. & Moemen, D. Bacterial biofilm dependent catheter associated urinary tract infections: characterization, antibiotic resistance pattern and risk factors. Egypt. J. Basic. Appl. Sci. 8, 64\u201374 (2021).","journal-title":"Egypt. J. Basic. Appl. Sci."},{"key":"1065_CR74","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/543974","volume":"2014","author":"SM Soto","year":"2014","unstructured":"Soto, S. M. Importance of biofilms in urinary tract infections: new therapeutic approaches. Adv. Biol. 2014, 543974 (2014).","journal-title":"Adv. Biol."},{"key":"1065_CR75","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/coatings10010023","volume":"10","author":"MJ Andersen","year":"2020","unstructured":"Andersen, M. J. & Flores-Mireles, A. L. Urinary catheter coating modifications: the race against catheter-associated infections. Coatings 10, 23 (2020).","journal-title":"Coatings"},{"key":"1065_CR76","doi-asserted-by":"publisher","first-page":"e01653","DOI":"10.1128\/mBio.01653-16","volume":"7","author":"AL Flores-Mireles","year":"2016","unstructured":"Flores-Mireles, A. L. et al. Antibody-based therapy for enterococcal catheter-associated urinary tract infections. mBio 7, e01653\u201316 (2016).","journal-title":"mBio"},{"key":"1065_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade7689","volume":"9","author":"AA La Bella","year":"2023","unstructured":"La Bella, A. A. et al. The catheterized bladder environment promotes Efg1- and Als1-dependent Candida albicans infection. Sci. Adv. 9, eade7689 (2023).","journal-title":"Sci. Adv."},{"key":"1065_CR78","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.juro.2016.01.100","volume":"196","author":"AL Flores-Mireles","year":"2016","unstructured":"Flores-Mireles, A. L. et al. Fibrinogen release and deposition on urinary catheters placed during urological procedures. J. Urol. 196, 416\u2013421 (2016).","journal-title":"J. Urol."},{"key":"1065_CR79","unstructured":"Chaudhry, R., Killeen, R. B. & Babiker H., M. Physiology, Coagulation Pathways. StatPearls [Internet] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482253\/ (updated 2 June 2025)."},{"key":"1065_CR80","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/infdis\/161.6.1177","volume":"161","author":"AL Cheung","year":"1990","unstructured":"Cheung, A. L. & Fischetti, V. A. The role of fibrinogen in staphylococcal adherence to catheters in vitro. J. Infect. Dis. 161, 1177\u20131186 (1990).","journal-title":"J. Infect. Dis."},{"key":"1065_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1221108","volume":"14","author":"F Bertoglio","year":"2023","unstructured":"Bertoglio, F. et al. Antibodies to coagulase of Staphylococcus aureus crossreact to Efb and reveal different binding of shared fibrinogen binding repeats. Front. Immunol. 14, 1221108 (2023).","journal-title":"Front. Immunol."},{"key":"1065_CR82","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.vetmic.2017.07.010","volume":"208","author":"Q Li","year":"2017","unstructured":"Li, Q. et al. Fibronectin-\/fibrinogen-binding protein (FBPS) is not a critical virulence factor for the Streptococcus suis serotype 2 strain ZY05719. Vet. Microbiol. 208, 38\u201346 (2017).","journal-title":"Vet. Microbiol."},{"key":"1065_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1228472","volume":"14","author":"AM Lapschies","year":"2023","unstructured":"Lapschies, A. M. et al. The type-2 Streptococcus canis M protein SCM-2 binds fibrinogen and facilitates antiphagocytic properties. Front. Microbiol. 14, 1228472 (2023).","journal-title":"Front. Microbiol."},{"key":"1065_CR84","unstructured":"National Healthcare Safety Network. Device Associated Module: Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-Associated Urinary Tract Infection [UTI]) Events. CDC https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/7psccauticurrent.pdf (2021)."},{"key":"1065_CR85","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/01.jps.0000205737.68588.d5","volume":"1","author":"JM Holroyd-Leduc","year":"2005","unstructured":"Holroyd-Leduc, J. M. et al. Risk factors for indwelling urinary catheterization among older hospitalized patients without a specific medical indication for catheterization. J. Patient Saf. 1, 201\u2013207 (2005).","journal-title":"J. Patient Saf."},{"key":"1065_CR86","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/postgradmedj-2020-139090","volume":"97","author":"R Kaur","year":"2020","unstructured":"Kaur, R. & Kaur, R. Symptoms, risk factors, diagnosis and treatment of urinary tract infections. Postgrad. Med. J. 97, 803\u2013812 (2020).","journal-title":"Postgrad. Med. J."},{"key":"1065_CR87","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41585-021-00477-x","volume":"18","author":"I Ambite","year":"2021","unstructured":"Ambite, I. et al. Molecular determinants of disease severity in urinary tract infection. Nat. Rev. Urol. 18, 468\u2013486 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"1065_CR88","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.ajkd.2023.08.009","volume":"83","author":"H Al Lawati","year":"2024","unstructured":"Al Lawati, H., Blair, B. M. & Larnard, J. Urinary tract infections: core curriculum 2024. Am. J. Kidney Dis. 83, 90\u2013100 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"1065_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20510","volume":"20","author":"AD Hay","year":"2016","unstructured":"Hay, A. D. et al. The diagnosis of urinary tract infection in young children (DUTY): a diagnostic prospective observational study to derive and validate a clinical algorithm for the diagnosis of urinary tract infection in children presenting to primary care with an acute illness. Health Technol. Assess. 20, 1\u2013294 (2016).","journal-title":"Health Technol. Assess."},{"key":"1065_CR90","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s00345-019-03027-8","volume":"38","author":"JN Walker","year":"2020","unstructured":"Walker, J. N. et al. High-resolution imaging reveals microbial biofilms on patient urinary catheters despite antibiotic administration. World J. Urol. 38, 2237\u20132245 (2020).","journal-title":"World J. Urol."},{"key":"1065_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44095-0","volume":"15","author":"TM Nye","year":"2024","unstructured":"Nye, T. M. et al. Microbial co-occurrences on catheters from long-term catheterized patients. Nat. Commun. 15, 61 (2024).","journal-title":"Nat. Commun."},{"key":"1065_CR92","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/pathogens9100835","volume":"9","author":"JR Gaston","year":"2020","unstructured":"Gaston, J. R. et al. Enterococcus faecalis polymicrobial interactions facilitate biofilm formation, antibiotic recalcitrance, and persistent colonization of the catheterized urinary tract. Pathogens 9, 835 (2020).","journal-title":"Pathogens"},{"key":"1065_CR93","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.144775","volume":"6","author":"CE Armbruster","year":"2021","unstructured":"Armbruster, C. E., Brauer, A. L., Humby, M. S., Shao, J. & Chakraborty, S. Prospective assessment of catheter-associated bacteriuria clinical presentation, epidemiology, and colonization dynamics in nursing home residents. JCI Insight 6, e144775 (2021).","journal-title":"JCI Insight"},{"key":"1065_CR94","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/jgs.14533","volume":"65","author":"CE Armbruster","year":"2017","unstructured":"Armbruster, C. E., Prenovost, K., Mobley, H. L. & Mody, L. How often do clinically diagnosed catheter-associated urinary tract infections in nursing homes meet standardized criteria? J. Am. Geriatr. Soc. 65, 395\u2013401 (2017).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1065_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04947-7","volume":"28","author":"X Qin","year":"2024","unstructured":"Qin, X. et al. Efficacy of expanded periurethral cleansing in reducing catheter-associated urinary tract infection in comatose patients: a randomized controlled clinical trial. Crit. Care 28, 162 (2024).","journal-title":"Crit. Care"},{"key":"1065_CR96","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/1040841X.2016.1240656","volume":"43","author":"AS Azevedo","year":"2017","unstructured":"Azevedo, A. S., Almeida, C., Melo, L. F. & Azevedo, N. F. Impact of polymicrobial biofilms in catheter-associated urinary tract infections. Crit. Rev. Microbiol. 43, 423\u2013439 (2017).","journal-title":"Crit. Rev. Microbiol."},{"key":"1065_CR97","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/postgradmedj-2012-131393","volume":"89","author":"M Melzer","year":"2013","unstructured":"Melzer, M. & Welch, C. Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections. Postgrad. Med. J. 89, 329\u2013334 (2013).","journal-title":"Postgrad. Med. J."},{"key":"1065_CR98","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/iju.12200","volume":"20","author":"FM Wagenlehner","year":"2013","unstructured":"Wagenlehner, F. M. et al. Diagnosis and management for urosepsis. Int. J. Urol. 20, 963\u2013970 (2013).","journal-title":"Int. J. Urol."},{"key":"1065_CR99","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0974-777X.62869","volume":"2","author":"A Nasr","year":"2010","unstructured":"Nasr, A. State of the globe: catheterizations continue to cultivate urinary infections. J. Glob. Infect. Dis. 2, 81\u201382 (2010).","journal-title":"J. Glob. Infect. Dis."},{"key":"1065_CR100","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1748-5908-6-41","volume":"6","author":"BW Trautner","year":"2011","unstructured":"Trautner, B. W. et al. A hospital-site controlled intervention using audit and feedback to implement guidelines concerning inappropriate treatment of catheter-associated asymptomatic bacteriuria. Implement. Sci. 6, 41 (2011).","journal-title":"Implement. Sci."},{"key":"1065_CR101","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1086\/597403","volume":"48","author":"M Cope","year":"2009","unstructured":"Cope, M. et al. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin. Infect. Dis. 48, 1182\u20131188 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"1065_CR102","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1086\/673456","volume":"34","author":"QF Kizilbash","year":"2013","unstructured":"Kizilbash, Q. F., Petersen, N. J., Chen, G. J., Naik, A. D. & Trautner, B. W. Bacteremia and mortality with urinary catheter-associated bacteriuria. Infect. Control. Hosp. Epidemiol. 34, 1153\u20131159 (2013).","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"1065_CR103","doi-asserted-by":"publisher","first-page":"254ra127","DOI":"10.1126\/scitranslmed.3009384","volume":"6","author":"AL Flores-Mireles","year":"2014","unstructured":"Flores-Mireles, A. L., Pinkner, J. S., Caparon, M. G. & Hultgren, S. J. EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Sci. Transl. Med. 6, 254ra127 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1065_CR104","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0092-8674(03)00809-2","volume":"115","author":"K Ponnuraj","year":"2003","unstructured":"Ponnuraj, K. et al. A \u201cdock, lock, and latch\u201d structural model for a staphylococcal adhesin binding to fibrinogen. Cell 115, 217\u2013228 (2003).","journal-title":"Cell"},{"key":"1065_CR105","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fcimb.2019.00106","volume":"9","author":"S Thomas","year":"2019","unstructured":"Thomas, S. et al. The complex fibrinogen interactions of the Staphylococcus aureus coagulases. Front. Cell Infect. Microbiol. 9, 106 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1065_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010227","volume":"18","author":"O Negron","year":"2022","unstructured":"Negron, O. et al. Fibrin(ogen) engagement of S. aureus promotes the host antimicrobial response and suppression of microbe dissemination following peritoneal infection. PLoS Pathog. 18, e1010227 (2022).","journal-title":"PLoS Pathog."},{"key":"1065_CR107","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jtha.2023.03.019","volume":"21","author":"O Negron","year":"2023","unstructured":"Negron, O. et al. Fibrinogen \u03b3\u2019 promotes host survival during Staphylococcus aureus septicemia in mice. J. Thromb. Haemost. 21, 2277\u20132290 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"1065_CR108","doi-asserted-by":"publisher","first-page":"E8721","DOI":"10.1073\/pnas.1707572114","volume":"114","author":"JN Walker","year":"2017","unstructured":"Walker, J. N. et al. Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract. Proc. Natl Acad. Sci. USA 114, E8721\u2013E8730 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1065_CR109","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1592\/phco.30.11.1136","volume":"30","author":"BH Heintz","year":"2010","unstructured":"Heintz, B. H., Halilovic, J. & Christensen, C. L. Vancomycin-resistant enterococcal urinary tract infections. Pharmacotherapy 30, 1136\u20131149 (2010).","journal-title":"Pharmacotherapy"},{"key":"1065_CR110","first-page":"25","volume":"43","author":"S Jayakumar","year":"2011","unstructured":"Jayakumar, S. et al. Short term urinary catheterized patients in intensive care unit (ICU) \u2014 a need to screen. J. Commun. Dis. 43, 25\u201330 (2011).","journal-title":"J. Commun. Dis."},{"key":"1065_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-017-0036-z","volume":"3","author":"W Xu","year":"2017","unstructured":"Xu, W. et al. Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection. NPJ Biofilms Microbiomes 3, 28 (2017).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"1065_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10706-y","volume":"10","author":"G Di Venanzio","year":"2019","unstructured":"Di Venanzio, G. et al. Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes. Nat. Commun. 10, 2763 (2019).","journal-title":"Nat. Commun."},{"key":"1065_CR113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2212694120","volume":"120","author":"KO Tamadonfar","year":"2023","unstructured":"Tamadonfar, K. O. et al. Structure\u2013function correlates of fibrinogen binding by Acinetobacter adhesins critical in catheter-associated urinary tract infections. Proc. Natl Acad. Sci. USA 120, e2212694120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1065_CR114","doi-asserted-by":"publisher","first-page":"eabn8134","DOI":"10.1126\/scitranslmed.abn8134","volume":"15","author":"JE Hazen","year":"2023","unstructured":"Hazen, J. E., Di Venanzio, G., Hultgren, S. J. & Feldman, M. F. Catheterization of mice triggers resurgent urinary tract infection seeded by a bladder reservoir of Acinetobacter baumannii. Sci. Transl. Med. 15, eabn8134 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1065_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1601944","volume":"3","author":"V Kalas","year":"2017","unstructured":"Kalas, V. et al. Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions. Sci. Adv. 3, e1601944 (2017).","journal-title":"Sci. Adv."},{"key":"1065_CR116","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/pr300813h","volume":"12","author":"B Adamczyk","year":"2013","unstructured":"Adamczyk, B., Struwe, W. B., Ercan, A., Nigrovic, P. A. & Rudd, P. M. Characterization of fibrinogen glycosylation and its importance for serum\/plasma N-glycome analysis. J. Proteome Res. 12, 444\u2013454 (2013).","journal-title":"J. Proteome Res."},{"key":"1065_CR117","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.mycmed.2017.04.005","volume":"27","author":"WA Alfouzan","year":"2017","unstructured":"Alfouzan, W. A. & Dhar, R. Candiduria: evidence-based approach to management, are we there yet? J. Mycol. Med. 27, 293\u2013302 (2017).","journal-title":"J. Mycol. Med."},{"key":"1065_CR118","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11908-000-0056-2","volume":"2","author":"JF Fisher","year":"2000","unstructured":"Fisher, J. F. Candiduria: when and how to treat it. Curr. Infect. Dis. Rep. 2, 523\u2013530 (2000).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"1065_CR119","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1439-0507.2008.01570.x","volume":"51","author":"E Hollenbach","year":"2008","unstructured":"Hollenbach, E. To treat or not to treat \u2014 critically ill patients with candiduria. Mycoses 51, 12\u201324 (2008).","journal-title":"Mycoses"},{"key":"1065_CR120","doi-asserted-by":"publisher","first-page":"S433","DOI":"10.1093\/cid\/cir109","volume":"52","author":"JD Sobel","year":"2011","unstructured":"Sobel, J. D., Fisher, J. F., Kauffman, C. A. & Newman, C. A. Candida urinary tract infections \u2014 epidemiology. Clin. Infect. Dis. 52, S433\u2013S436 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"1065_CR121","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4103\/0377-4929.85091","volume":"54","author":"M Jain","year":"2011","unstructured":"Jain, M. et al. Candiduria in catheterized intensive care unit patients: emerging microbiological trends. Indian J. Pathol. Microbiol. 54, 552\u2013555 (2011).","journal-title":"Indian J. Pathol. Microbiol."},{"key":"1065_CR122","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5152\/tud.2018.54069","volume":"44","author":"M Gharaghani","year":"2018","unstructured":"Gharaghani, M., Taghipour, S., Halvaeezadeh, M. & Mahmoudabadi, A. Z. Candiduria; a review article with specific data from Iran. Turk. J. Urol. 44, 445\u2013452 (2018).","journal-title":"Turk. J. Urol."},{"key":"1065_CR123","first-page":"DC11","volume":"9","author":"MS Rishpana","year":"2015","unstructured":"Rishpana, M. S. & Kabbin, J. S. Candiduria in catheter associated urinary tract infection with special reference to biofilm production. J. Clin. Diagn. Res. 9, DC11\u2013DC13 (2015).","journal-title":"J. Clin. Diagn. Res."},{"key":"1065_CR124","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/sc.2009.81","volume":"48","author":"LL Goetz","year":"2010","unstructured":"Goetz, L. L., Howard, M., Cipher, D. & Revankar, S. G. Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury. Spinal Cord. 48, 51\u201354 (2010).","journal-title":"Spinal Cord."},{"key":"1065_CR125","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.939088","volume":"28","author":"DV Parums","year":"2022","unstructured":"Parums, D. V. Editorial: the World Health Organization (WHO) fungal priority pathogens list in response to emerging fungal pathogens during the COVID-19 pandemic. Med. Sci. Monit. 28, e939088 (2022).","journal-title":"Med. Sci. Monit."},{"key":"1065_CR126","unstructured":"Organization, W. H. WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. (World Health Organization, 2022)."},{"key":"1065_CR127","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/antibiotics9120898","volume":"9","author":"N Griffith","year":"2020","unstructured":"Griffith, N. & Danziger, L. Candida auris urinary tract infections and possible treatment. Antibiotics 9, 898 (2020).","journal-title":"Antibiotics"},{"key":"1065_CR128","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.ajic.2015.03.013","volume":"43","author":"D Padawer","year":"2015","unstructured":"Padawer, D. et al. Catheter-associated candiduria: risk factors, medical interventions, and antifungal susceptibility. Am. J. Infect. Control. 43, e19\u2013e22 (2015).","journal-title":"Am. J. Infect. Control."},{"key":"1065_CR129","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00134-003-1807-y","volume":"29","author":"F \u00c1lvarez-Lerma","year":"2003","unstructured":"\u00c1lvarez-Lerma, F. et al. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med. 29, 1069\u20131076 (2003).","journal-title":"Intensive Care Med."},{"key":"1065_CR130","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4414\/smw.2004.10319","volume":"134","author":"B Walder","year":"2004","unstructured":"Walder, B. & Tramer, M. R. Analgesia and sedation in critically ill patients. Swiss Med. Wkly. 134, 333\u2013346 (2004).","journal-title":"Swiss Med. Wkly."},{"key":"1065_CR131","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s00345-019-03027-8","volume":"38","author":"JN Walker","year":"2019","unstructured":"Walker, J. N. et al. High-resolution imaging reveals microbial biofilms on patient urinary catheters despite antibiotic administration. World J. Urol. 38, 2237\u20132245 (2019).","journal-title":"World J. Urol."},{"key":"1065_CR132","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/CMR.17.2.255-267.2004","volume":"17","author":"EM Kojic","year":"2004","unstructured":"Kojic, E. M. & Darouiche, R. O. Candida infections of medical devices. Clin. Microbiol. Rev. 17, 255\u2013267 (2004).","journal-title":"Clin. Microbiol. Rev."},{"key":"1065_CR133","first-page":"475","volume":"46","author":"M Azmy","year":"2016","unstructured":"Azmy, M., Nawar, N., Mohiedden, M. & Warille, L. Electron microscopic assay of bacterial biofilm formed on indwelling urethral catheters. J. Egypt. Soc. Parasitol. 46, 475\u2013484 (2016).","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"1065_CR134","doi-asserted-by":"publisher","first-page":"S437","DOI":"10.1093\/cid\/cir110","volume":"52","author":"JF Fisher","year":"2011","unstructured":"Fisher, J. F., Kavanagh, K., Sobel, J. D., Kauffman, C. A. & Newman, C. A. Candida urinary tract infection: pathogenesis. Clin. Infect. Dis. 52, S437\u2013S451 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"1065_CR135","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s00345-019-03027-8","volume":"38","author":"JN Walker","year":"2018","unstructured":"Walker, J. N. et al. High-resolution imaging reveals microbial biofilms on patient urinary catheters despite antibiotic administration. World J. Urol. 38, 2237\u20132245 (2018). 2020 Sep.","journal-title":"World J. Urol."},{"key":"1065_CR136","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1099\/jmm.0.000575","volume":"66","author":"I Zeller","year":"2017","unstructured":"Zeller, I. et al. Detection of fungal pathogens by a new broad range real-time PCR assay targeting the fungal ITS2 region. J. Med. Microbiol. 66, 1383\u20131392 (2017).","journal-title":"J. Med. Microbiol."},{"key":"1065_CR137","first-page":"209","volume":"72","author":"M Gajdacs","year":"2019","unstructured":"Gajdacs, M., Doczi, I., Abrok, M., Lazar, A. & Burian, K. Epidemiology of candiduria and Candida urinary tract infections in inpatients and outpatients: results from a 10-year retrospective survey. Cent. European J. Urol. 72, 209\u2013214 (2019).","journal-title":"Cent. European J. Urol."},{"key":"1065_CR138","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6935","volume":"7","author":"Z He","year":"2019","unstructured":"He, Z. et al. Candiduria in hospitalized patients: an investigation with the Sysmex UF-1000i urine analyzer. PeerJ 7, e6935 (2019).","journal-title":"PeerJ"},{"key":"1065_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.930495","volume":"13","author":"H Li","year":"2022","unstructured":"Li, H. et al. Interactions between Candida albicans and the resident microbiota. Front. Microbiol. 13, 930495 (2022).","journal-title":"Front. Microbiol."},{"key":"1065_CR140","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/S0924-8579(08)70006-2","volume":"32","author":"E Bouza","year":"2008","unstructured":"Bouza, E. & Munoz, P. Epidemiology of candidemia in intensive care units. Int. J. Antimicrob. Agents 32, S87\u2013S91 (2008).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1065_CR141","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ccm.2017.04.010","volume":"38","author":"O Epelbaum","year":"2017","unstructured":"Epelbaum, O. & Chasan, R. Candidemia in the intensive care unit. Clin. Chest Med. 38, 493\u2013509 (2017).","journal-title":"Clin. Chest Med."},{"key":"1065_CR142","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/00041552-199411000-00017","volume":"3","author":"Y Siegman-Igra","year":"1994","unstructured":"Siegman-Igra, Y. The significance of urine culture with mixed flora. Curr. Opin. Nephrol. Hypertens. 3, 656\u2013659 (1994).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"1065_CR143","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1532-5415.1988.tb07175.x","volume":"36","author":"D Rudman","year":"1988","unstructured":"Rudman, D., Hontanosas, A., Cohen, Z. & Mattson, D. E. Clinical correlates of bacteremia in a veterans administration extended care facility. J. Am. Geriatr. Soc. 36, 726\u2013732 (1988).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1065_CR144","unstructured":"Lee, H. S. & Le, J. in Infectious Diseases, (eds Huang, V., et al.) 7\u201328. (American College of Clinical Pharmacology, 2018)."},{"key":"1065_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.667462","volume":"8","author":"Y Yu","year":"2021","unstructured":"Yu, Y. et al. Urethral catheter biofilms reveal plasticity in bacterial composition and metabolism and withstand host immune defenses in hypoxic environment. Front. Med. 8, 667462 (2021).","journal-title":"Front. Med."},{"key":"1065_CR146","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/bit.28241","volume":"120","author":"J Allkja","year":"2023","unstructured":"Allkja, J., Goeres, D. M., Azevedo, A. S. & Azevedo, N. F. Interactions of microorganisms within a urinary catheter polymicrobial biofilm model. Biotechnol. Bioeng. 120, 239\u2013249 (2023).","journal-title":"Biotechnol. Bioeng."},{"key":"1065_CR147","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3389\/fmicb.2020.02017","volume":"11","author":"M Al-Balawi","year":"2020","unstructured":"Al-Balawi, M. & Morsy, F. M. Enterococcus faecalis is a better competitor than other lactic acid bacteria in the initial colonization of colon of healthy newborn babies at first week of their life. Front. Microbiol. 11, 2017 (2020).","journal-title":"Front. Microbiol."},{"key":"1065_CR148","unstructured":"United States Center for Disease Control and Prevention. HAI Pathogens and Antimicrobial Resistance Report, 2018\u20132021. CDC https:\/\/www.cdc.gov\/nhsn\/hai-report\/index.html (2023)."},{"key":"1065_CR149","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.mpmed.2011.04.003","volume":"39","author":"NS Sheerin","year":"2011","unstructured":"Sheerin, N. S. Urinary tract infection. Medicine 39, 384\u2013389 (2011).","journal-title":"Medicine"},{"key":"1065_CR150","first-page":"226","volume":"1","author":"M Komala","year":"2013","unstructured":"Komala, M. & Kumar, K. S. Urinary tract infection: causes, symptoms, diagnosis and its management. Indian J. Res. Pharm. Biotechnol. 1, 226 (2013).","journal-title":"Indian J. Res. Pharm. Biotechnol."},{"key":"1065_CR151","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.mpmed.2019.06.008","volume":"47","author":"NS Sheerin","year":"2019","unstructured":"Sheerin, N. S. & Glover, E. K. Urinary tract infection. Medicine 47, 546\u2013550 (2019).","journal-title":"Medicine"},{"key":"1065_CR152","first-page":"26","volume":"88","author":"S Danchaivijitr","year":"2005","unstructured":"Danchaivijitr, S., Dhiraputra, C., Cherdrungsi, R., Jintanothaitavorn, D. & Srihapol, N. Catheter-associated urinary tract infection. J. Med. Assoc. Thai 88, 26\u201330 (2005).","journal-title":"J. Med. Assoc. Thai"},{"key":"1065_CR153","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1016\/j.ajic.2014.05.024","volume":"42","author":"J Meddings","year":"2014","unstructured":"Meddings, J., Reichert, H. & McMahon, L. F. Jr Challenges and proposed improvements for reviewing symptoms and catheter use to identify national healthcare safety network catheter-associated urinary tract infections. Am. J. Infect. Control. 42, S236\u2013S241 (2014).","journal-title":"Am. J. Infect. Control."},{"key":"1065_CR154","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/archinte.160.5.678","volume":"160","author":"PA Tambyah","year":"2000","unstructured":"Tambyah, P. A. & Maki, D. G. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1497 catheterized patients. Arch. Intern. Med. 160, 678\u2013682 (2000).","journal-title":"Arch. Intern. Med."},{"key":"1065_CR155","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1054773814550506","volume":"24","author":"TJ Blodgett","year":"2015","unstructured":"Blodgett, T. J., Gardner, S. E., Blodgett, N. P., Peterson, L. V. & Pietraszak, M. A tool to assess the signs and symptoms of catheter-associated urinary tract infection: development and reliability. Clin. Nurs. Res. 24, 341\u2013356 (2015).","journal-title":"Clin. Nurs. Res."},{"key":"1065_CR156","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0033-1351138","volume":"26","author":"V Garimella","year":"2013","unstructured":"Garimella, V. & Cellini, C. Postoperative pain control. Clin. Colon. Rectal Surg. 26, 191\u2013196 (2013).","journal-title":"Clin. Colon. Rectal Surg."},{"key":"1065_CR157","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.medmal.2019.02.006","volume":"49","author":"A Dinh","year":"2019","unstructured":"Dinh, A. et al. Urinary tract infections in patients with neurogenic bladder. Med. Mal. Infect. 49, 495\u2013504 (2019).","journal-title":"Med. Mal. Infect."},{"key":"1065_CR158","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41579-024-01092-4","volume":"23","author":"MR Timm","year":"2025","unstructured":"Timm, M. R., Russell, S. K. & Hultgren, S. J. Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics. Nat. Rev. Microbiol. 23, 72\u201386 (2025).","journal-title":"Nat. Rev. Microbiol."},{"key":"1065_CR159","doi-asserted-by":"publisher","DOI":"10.1177\/1756287218814382","volume":"11","author":"O Storme","year":"2019","unstructured":"Storme, O., Tiran Saucedo, J., Garcia-Mora, A., Dehesa-Davila, M. & Naber, K. G. Risk factors and predisposing conditions for urinary tract infection. Ther. Adv. Urol. 11, 1756287218814382 (2019).","journal-title":"Ther. Adv. Urol."},{"key":"1065_CR160","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlae179","volume":"6","author":"CML Mwansa","year":"2024","unstructured":"Mwansa, C. M. L., Babiker, A., Satola, S., Logan, L. K. & Nadimpalli, M. L. Associations between neighbourhood-level median household income and outpatients\u2019 risk of antibiotic non-susceptible uropathogens in a major urban centre, USA. JAC Antimicrob. Resist. 6, dlae179 (2024).","journal-title":"JAC Antimicrob. Resist."},{"key":"1065_CR161","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s11606-024-09029-6","volume":"40","author":"DL Fromer","year":"2024","unstructured":"Fromer, D. L. et al. Risk factors for empiric treatment failure in US female outpatients with uncomplicated urinary tract infection: an observational study. J. Gen. Intern. Med. 40, 862\u2013870 (2024).","journal-title":"J. Gen. Intern. Med."},{"key":"1065_CR162","unstructured":"Bono, M. J., Leslie, S. W. & Reygaert, W. C. Uncomplicated Urinary Tract Infections. StatPearls [Internet] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470195\/ (updated 21 February 2025)."},{"key":"1065_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.152020","volume":"226","author":"A Sen","year":"2021","unstructured":"Sen, A., Kaul, A. & Kaul, R. Estrogen receptors in human bladder cells regulate innate cytokine responses to differentially modulate uropathogenic E. coli colonization. Immunobiology 226, 152020 (2021).","journal-title":"Immunobiology"},{"key":"1065_CR164","doi-asserted-by":"publisher","first-page":"e1101","DOI":"10.1093\/infdis\/jiae331","volume":"230","author":"BK Ackerson","year":"2024","unstructured":"Ackerson, B. K. et al. Risk factors for recurrent urinary tract infections among women in a large integrated health care organization in the United States. J. Infect. Dis. 230, e1101\u2013e1111 (2024).","journal-title":"J. Infect. Dis."},{"key":"1065_CR165","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/JU.0000000000000296","volume":"202","author":"J Anger","year":"2019","unstructured":"Anger, J. et al. Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline. J. Urol. 202, 282\u2013289 (2019).","journal-title":"J. Urol."},{"key":"1065_CR166","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/bmjqs-2012-001774","volume":"23","author":"J Meddings","year":"2014","unstructured":"Meddings, J. et al. Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review. BMJ Qual. Saf. 23, 277\u2013289 (2014).","journal-title":"BMJ Qual. Saf."},{"key":"1065_CR167","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/S0022-5347(05)67150-9","volume":"164","author":"R Raz","year":"2000","unstructured":"Raz, R., Schiller, D. & Nicolle, L. E. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J. Urol. 164, 1254\u20131258 (2000).","journal-title":"J. Urol."},{"key":"1065_CR168","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1111\/jgs.15517","volume":"66","author":"T Babich","year":"2018","unstructured":"Babich, T. et al. Replacement of urinary catheter for urinary tract infections: a prospective observational study. J. Am. Geriatr. Soc. 66, 1779\u20131784 (2018).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1065_CR169","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/PRS.0000000000008884","volume":"149","author":"K Ausen","year":"2022","unstructured":"Ausen, K., Fossmark, R., Spigset, O. & Pleym, H. Safety and efficacy of local tranexamic acid for the prevention of surgical bleeding in soft-tissue surgery: a review of the literature and recommendations for plastic surgery. Plast. Reconstr. Surg. 149, 774\u2013787 (2022).","journal-title":"Plast. Reconstr. Surg."},{"key":"1065_CR170","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12028-020-01020-3","volume":"34","author":"K Perrin","year":"2021","unstructured":"Perrin, K. et al. Catheter-associated urinary tract infection (CAUTI) in the NeuroICU: identification of risk factors and time-to-CAUTI using a case-control design. Neurocrit Care 34, 271\u2013278 (2021).","journal-title":"Neurocrit Care"},{"key":"1065_CR171","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283450","volume":"18","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Income-related inequalities in diagnosed diabetes prevalence among US adults, 2001\u20132018. PLoS ONE 18, e0283450 (2023).","journal-title":"PLoS ONE"},{"key":"1065_CR172","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-021-00758-x","volume":"23","author":"J Chen","year":"2021","unstructured":"Chen, J., Khazanchi, R., Bearman, G. & Marcelin, J. R. Racial\/ethnic inequities in healthcare-associated infections under the shadow of structural racism: narrative review and call to action. Curr. Infect. Dis. Rep. 23, 17 (2021).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"1065_CR173","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3390\/jcm10112419","volume":"10","author":"X Li","year":"2021","unstructured":"Li, X. et al. Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis. J. Clin. Med. 10, 2419 (2021).","journal-title":"J. Clin. Med."},{"key":"1065_CR174","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12933-021-01372-w","volume":"20","author":"AH Bryk-Wiazania","year":"2021","unstructured":"Bryk-Wiazania, A. H. & Undas, A. Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation. Cardiovasc. Diabetol. 20, 191 (2021).","journal-title":"Cardiovasc. Diabetol."},{"key":"1065_CR175","unstructured":"Cronkleton, E. What Medication Can Treat a Urinary Tract Infection (UTI)? Healthline https:\/\/www.healthline.com\/health\/medicine-for-urinary-tract-infection#oral-antibiotics (2023)."},{"key":"1065_CR176","doi-asserted-by":"publisher","first-page":"e02359","DOI":"10.1128\/spectrum.02359-21","volume":"10","author":"MW Dunne","year":"2022","unstructured":"Dunne, M. W. et al. Impact of empirical antibiotic therapy on outcomes of outpatient urinary tract infection due to nonsusceptible Enterobacterales. Microbiol. Spectr. 10, e02359\u201302321 (2022).","journal-title":"Microbiol. Spectr."},{"key":"1065_CR177","unstructured":"Aggarwal, N. & Leslie, S. W. Recurrent Urinary Tract Infections. StatPearls [Internet] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557479\/ (updated 20 January 2025)."},{"key":"1065_CR178","unstructured":"Lee, H. S. & Le, J. in Infectious Diseases (eds Huang, V. et al.) 7\u201328 (PSAP, 2018)."},{"key":"1065_CR179","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40265-024-02137-x","volume":"85","author":"D Heimann","year":"2025","unstructured":"Heimann, D., Kohnh\u00e4user, D., Kohnh\u00e4user, A. J. & Br\u00f6nstrup, M. Antibacterials with novel chemical scaffolds in clinical development. Drugs 85, 293\u2013323 (2025).","journal-title":"Drugs"},{"key":"1065_CR180","unstructured":"Sabih, A. & Leslie, S. W. Complicated Urinary Tract Infections. StatPearls [Internet] https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK436013\/ (updated 7 December 2024)."},{"key":"1065_CR181","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.52314","volume":"7","author":"S Tingsgard","year":"2024","unstructured":"Tingsgard, S., Bastrup Israelsen, S., Jorgensen, H. L., Ostergaard, C. & Benfield, T. Early switch from intravenous to oral antibiotics for patients with uncomplicated gram-negative bacteremia. JAMA Netw. Open\u00a07, e2352314 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1065_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101750","volume":"55","author":"A Turjeman","year":"2023","unstructured":"Turjeman, A. et al. Duration of antibiotic treatment for gram-negative bacteremia \u2014 systematic review and individual participant data (IPD) meta-analysis. EClinicalMedicine 55, 101750 (2023).","journal-title":"EClinicalMedicine"},{"key":"1065_CR183","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4161\/viru.21282","volume":"3","author":"BL Hollenbeck","year":"2012","unstructured":"Hollenbeck, B. L. & Rice, L. B. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence 3, 421\u2013433 (2012).","journal-title":"Virulence"},{"key":"1065_CR184","doi-asserted-by":"publisher","first-page":"1319\u2013","DOI":"10.1016\/S1473-3099(24)00424-9","volume":"24","author":"P Kim","year":"2024","unstructured":"Kim, P. et al. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Lancet Infect. Dis. 24, 1319\u20131332 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1065_CR185","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.3390\/biomedicines10102580","volume":"10","author":"SPY Kanti","year":"2022","unstructured":"Kanti, S. P. Y., Csoka, I., Jojart-Laczkovich, O. & Adalbert, L. Recent advances in antimicrobial coatings and material modification strategies for preventing urinary catheter-associated complications. Biomedicines 10, 2580 (2022).","journal-title":"Biomedicines"},{"key":"1065_CR186","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jiph.2019.09.009","volume":"12","author":"M Al-Qahtani","year":"2019","unstructured":"Al-Qahtani, M., Safan, A., Jassim, G. & Abadla, S. Efficacy of anti-microbial catheters in preventing catheter associated urinary tract infections in hospitalized patients: a review on recent updates. J. Infect. Public. Health 12, 760\u2013766 (2019).","journal-title":"J. Infect. Public. Health"},{"key":"1065_CR187","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/1040841X.2023.2167593","volume":"50","author":"J Chadha","year":"2024","unstructured":"Chadha, J., Thakur, N., Chhibber, S. & Harjai, K. A comprehensive status update on modification of Foley catheter to combat catheter-associated urinary tract infections and microbial biofilms. Crit. Rev. Microbiol. 50, 168\u2013195 (2024).","journal-title":"Crit. Rev. Microbiol."},{"key":"1065_CR188","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1097\/00005344-200605001-00015","volume":"47","author":"SA Schug","year":"2006","unstructured":"Schug, S. A. The role of COX-2 inhibitors in the treatment of postoperative pain. J. Cardiovasc. Pharmacol. 47, S82\u2013S86 (2006).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"1065_CR189","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3945\/ajcn.116.130542","volume":"103","author":"KC Maki","year":"2016","unstructured":"Maki, K. C. et al. Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection. Am. J. Clin. Nutr. 103, 1434\u20131442 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"1065_CR190","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-021-00811-w","volume":"21","author":"A Babar","year":"2021","unstructured":"Babar, A. et al. High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a double-blind randomized controlled trial. BMC Urol. 21, 44 (2021).","journal-title":"BMC Urol."},{"key":"1065_CR191","volume":"8","author":"TE Cooper","year":"2022","unstructured":"Cooper, T. E. et al. D\u2010mannose for preventing and treating urinary tract infections. Cochrane Database Syst. Rev. 8, CD013608 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1065_CR192","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamainternmed.2024.0264","volume":"184","author":"G Hayward","year":"2024","unstructured":"Hayward, G. et al. d-Mannose for prevention of recurrent urinary tract infection among women: a randomized clinical trial. JAMA Intern. Med. 184, 619\u2013628 (2024).","journal-title":"JAMA Intern. Med."},{"key":"1065_CR193","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.urology.2024.07.015","volume":"193","author":"AA La Bella","year":"2024","unstructured":"La Bella, A. A., Molesan, A., Wollin, D. A., Paul, S. & Flores-Mireles, A. L. Initial antimicrobial testing of a novel reusable intermittent urinary catheter system and catheter reprocessing device. Urology 193, 8\u201315 (2024).","journal-title":"Urology"},{"key":"1065_CR194","unstructured":"Etefia, E. in Escherichia coli \u2014 Old and New Insights (ed. Erjavec, M. S.) (IntechOpen, 2021)."},{"key":"1065_CR195","unstructured":"Carere-Sigl, A., Nowakowska, J., Hevey, R., Khanna, N. & Ernst, B. in Carbohydrate Chemistry: Chemical and Biological Approaches, Volume 45 (eds Rauter, A. P., Lindhorst, T. K., Queneau. Y. (Royal Society of Chemistry, 2021)."},{"key":"1065_CR196","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/pathogens5010030","volume":"5","author":"CN Spaulding","year":"2016","unstructured":"Spaulding, C. N. & Hultgren, S. J. Adhesive pili in UTI pathogenesis and drug development. Pathogens 5, 30 (2016).","journal-title":"Pathogens"},{"key":"1065_CR197","doi-asserted-by":"publisher","first-page":"1449.e1441","DOI":"10.1016\/j.cmi.2023.07.024","volume":"29","author":"CV Chagneau","year":"2023","unstructured":"Chagneau, C. V. et al. HlyF, an underestimated virulence factor of uropathogenic Escherichia coli. Clin. Microbiol. Infect. 29, 1449.e1441\u20131449.e1449 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"1065_CR198","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-024-00600-4","volume":"16","author":"R Tanaka","year":"2024","unstructured":"Tanaka, R. et al. Cyclic-di-AMP confers an invasive phenotype on Escherichia coli through elongation of flagellin filaments. Gut Pathog. 16, 6 (2024).","journal-title":"Gut Pathog."},{"key":"1065_CR199","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/959206","volume":"2014","author":"DA Lopez-Banda","year":"2014","unstructured":"Lopez-Banda, D. A. et al. Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico. Biomed. Res. Int. 2014, 959206 (2014).","journal-title":"Biomed. Res. Int."},{"key":"1065_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06435-7","volume":"21","author":"GK Bunduki","year":"2021","unstructured":"Bunduki, G. K. et al. Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis. BMC Infect. Dis. 21, 753 (2021).","journal-title":"BMC Infect. Dis."},{"key":"1065_CR201","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.161461","volume":"8","author":"Z Zou","year":"2023","unstructured":"Zou, Z. et al. E. coli catheter-associated urinary tract infections are associated with distinctive virulence and biofilm gene determinants. JCI Insight 8, e161461 (2023).","journal-title":"JCI Insight"},{"key":"1065_CR202","first-page":"1","volume":"17","author":"EH Mohamed","year":"2024","unstructured":"Mohamed, E. H. et al. Study of biofilm, virulence genes, and risk factors in urinary catheter-associated Escherichia coli infections. Jundishapur J. Microbiol. 17, 1\u20139 (2024).","journal-title":"Jundishapur J. Microbiol."},{"key":"1065_CR203","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409655121","volume":"121","author":"EDB Lopatto","year":"2024","unstructured":"Lopatto, E. D. B. et al. Conformational ensembles in Klebsiella pneumoniae FimH impact uropathogenesis. Proc. Natl Acad. Sci. USA 121, e2409655121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1065_CR204","doi-asserted-by":"crossref","unstructured":"Clegg, S. & Murphy, C. N. in Urinary Tract Infections: Molecular Pathogenesis and Clinical Management (eds. Mulvey, M. A. et al.) 435-457 (Oxford Univ. Press, 2017).","DOI":"10.1128\/9781555817404.ch18"},{"key":"1065_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcsw.2022.100075","volume":"8","author":"DK Govindarajan","year":"2022","unstructured":"Govindarajan, D. K. & Kandaswamy, K. Virulence factors of uropathogens and their role in host pathogen interactions. Cell Surf. 8, 100075 (2022).","journal-title":"Cell Surf."},{"key":"1065_CR206","doi-asserted-by":"publisher","unstructured":"Schaffer, J. N. & Pearson, M. M. Proteus mirabilis and urinary tract infections. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0017-2013 (2015).","DOI":"10.1128\/microbiolspec.UTI-0017-2013"},{"key":"1065_CR207","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fcimb.2020.00414","volume":"10","author":"R Wasfi","year":"2020","unstructured":"Wasfi, R., Hamed, S. M., Amer, M. A. & Fahmy, L. I. Proteus mirabilis biofilm: development and therapeutic strategies. Front. Cell Infect. Microbiol. 10, 414 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"1065_CR208","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnx124","volume":"364","author":"JW Newman","year":"2017","unstructured":"Newman, J. W., Floyd, R. V. & Fothergill, J. L. The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections. FEMS Microbiol. Lett. 364, fnx124 (2017).","journal-title":"FEMS Microbiol. Lett."},{"key":"1065_CR209","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MMBR.00043-12","volume":"77","author":"U Romling","year":"2013","unstructured":"Romling, U., Galperin, M. Y. & Gomelsky, M. Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol. Mol. Biol. Rev. 77, 1\u201352 (2013).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1065_CR210","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1128\/IAI.01652-14","volume":"82","author":"SJ Cole","year":"2014","unstructured":"Cole, S. J., Records, A. R., Orr, M. W., Linden, S. B. & Lee, V. T. Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms. Infect. Immun. 82, 2048\u20132058 (2014).","journal-title":"Infect. Immun."},{"key":"1065_CR211","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00258-22","volume":"13","author":"CD Jackson-Litteken","year":"2022","unstructured":"Jackson-Litteken, C. D. et al. InvL, an invasin-like adhesin, is a type II secretion system substrate required for Acinetobacter baumannii uropathogenesis. mBio 13, e0025822 (2022).","journal-title":"mBio"},{"key":"1065_CR212","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00365-21","volume":"89","author":"S Kundra","year":"2021","unstructured":"Kundra, S. et al. c-di-AMP is essential for the virulence of Enterococcus faecalis. Infect. Immun. 89, e0036521 (2021).","journal-title":"Infect. Immun."},{"key":"1065_CR213","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007102","volume":"14","author":"C Colomer-Winter","year":"2018","unstructured":"Colomer-Winter, C. et al. Manganese acquisition is essential for virulence of Enterococcus faecalis. PLoS Pathog. 14, e1007102 (2018).","journal-title":"PLoS Pathog."},{"key":"1065_CR214","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/21505594.2022.2056965","volume":"13","author":"LN Lam","year":"2022","unstructured":"Lam, L. N., Brunson, D. N., Molina, J. J., Flores-Mireles, A. L. & Lemos, J. A. The AdcACB\/AdcAII system is essential for zinc homeostasis and an important contributor of Enterococcus faecalis virulence. Virulence 13, 592\u2013608 (2022).","journal-title":"Virulence"},{"key":"1065_CR215","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1101754","volume":"14","author":"K Xu","year":"2023","unstructured":"Xu, K. et al. Staphylococcus aureus ST1 promotes persistent urinary tract infection by highly expressing the urease. Front. Microbiol. 14, 1101754 (2023).","journal-title":"Front. Microbiol."},{"key":"1065_CR216","doi-asserted-by":"publisher","first-page":"e05365","DOI":"10.1128\/spectrum.05365-22","volume":"11","author":"S Paudel","year":"2023","unstructured":"Paudel, S. et al. Defining the roles of pyruvate oxidation, TCA cycle, and mannitol metabolism in methicillin-resistant Staphylococcus aureus catheter-associated urinary tract infection. Microbiol. Spectr. 11, e05365\u2013e05322 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1065_CR217","first-page":"179","volume":"1","author":"MG Ismail","year":"2020","unstructured":"Ismail, M. G., El-Haliem, A., Farouk, N. & Aboelmagd, E. K. Assessment of virulence factors and antifungal susceptibility of Candida species isolated from catheter associated urinary tract infections. Al-Azhar Int. Med. J. 1, 179\u2013188 (2020).","journal-title":"Al-Azhar Int. Med. J."},{"key":"1065_CR218","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022137","volume":"9","author":"AS Letica-Kriegel","year":"2019","unstructured":"Letica-Kriegel, A. S. et al. Identifying the risk factors for catheter-associated urinary tract infections: a large cross-sectional study of six hospitals. BMJ Open\u00a09, e022137 (2019).","journal-title":"BMJ Open"},{"key":"1065_CR219","volume":"13","author":"M Shankar","year":"2021","unstructured":"Shankar, M., Narasimhappa, S. & Madhura, N. S. Urinary tract infection in chronic kidney disease population: a clinical observational study. Cureus 13, e12486 (2021).","journal-title":"Cureus"}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01065-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:02:10Z","timestamp":1764550930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-025-01065-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":219,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1038\/s41585-025-01065-z","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"23 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}